# BEAM: Brain-Eye Amyloid Memory Study

> **NCT02524405** · — · UNKNOWN · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 345 (estimated)

## Conditions studied

- Alzheimer's Disease
- Mild Cognitive Impairment
- Vascular Cognitive Impairment
- Parkinson's Disease
- Lewy Body Disease

## Interventions

- **OTHER:** Pittsburgh Compound B [11C]-PIB

## Key facts

- **NCT ID:** NCT02524405
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02
- **Primary completion:** 2025-03
- **Final completion:** 2025-03
- **Target enrollment:** 345 (ESTIMATED)
- **Last updated:** 2024-04-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02524405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02524405, "BEAM: Brain-Eye Amyloid Memory Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02524405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*